Taxotere Hair Loss Articles
May 15, 2017. By Gordon Gibb.
Washington, DC: A recent filing by Taxotere manufacturer Sanofi Aventis with the US Securities and Exchange Commission (SEC) revealed the current state of Taxotere hair loss lawsuits as of the end of the pharmaceutical’s fiscal year ending December 31, 2016.Read [ Taxotere Hair Loss Patients Speak Out Over the Fallout ]
April 20, 2017. By Gordon Gibb.
New Orleans, LA: An interesting sidebar to Taxotere hair loss litigation has opened up through a peek into docetaxel hair loss multidistrict litigation, and an accompanying analysis of the various approval protocols employed to bring both branded and generic docetaxel (Taxotere) to the market.Read [ Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol ]
April 7, 2017. By Deb Hipp.
New Orleans, LA A multidistrict litigation of hundreds of Taxotere lawsuits alleging that the chemotherapy drug Taxotere causes permanent hair loss continues to move forward in federal court with a "Science Day" scheduled in May.Read [ Science Day Scheduled For Taxotere Multidistrict Litigation ]
March 29, 2017. By Brenda Craig.
San Francisco, CA In 2010, Ami Dodson was diagnosed with stage two breast cancer and underwent a partial mastectomy to remove the cancer. Her oncologists suggested they follow up with chemotherapy treatments using a drug known as Taxotere. Her prognosis was excellent and there was every expectation she would live a normal life.Read [ California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims ]
March 4, 2017. By Gordon Gibb.
New Orleans, LA: As important as it is to be aware of any, and all side effects associated with a drug such as Taxotere, patients in need of the chemotherapy drug are already coming from a position of significant physical and emotional challenge: the fallout from a cancer diagnosis. And while most cancer patients are aware that hair loss is a common byproduct of chemotherapy and cancer treatments, many would not be cognizant about the potential for Taxotere hair loss to be permanent.Read [ Potential for Permanent Taxotere Hair Loss Not Widely Promoted ]
February 27, 2017. By Deb Hipp.
New Orleans, LA: In a joint report filed in federal court in January, attorneys representing plaintiffs and defendant Sanofi S.A. in multidistrict litigation of Taxotere lawsuits reported a spike in the number of lawsuits alleging that the chemotherapy drug Taxotere causes permanent hair loss, a condition known as alopecia.Read [ Number of Taxotere MDL Lawsuits Surpasses 700 Cases ]
February 15, 2017. By Gordon Gibb.
New Orleans, LA: The 800 lawsuits currently enshrouded in Taxotere hair loss multidistrict litigation are moving forward by way of updated orders and directives issued February 1 by the US District Court for the Eastern District of Louisiana. Plaintiffs assert that Taxotere, a chemotherapy drug, triggered Taxotere alopecia (hair loss) that has been characterized as permanent.Read [ Taxotere Hair Loss Lawsuits Moving Forward in MDL ]
January 22, 2017. By Gordon Gibb.
Washington, DC: The Taxotere hair loss lawsuit file continues to move forward, with various Pretrial Orders issued in the early part of the New Year with proposed Plaintiff and Defendant fact sheets due to be filed Monday (January 23). Meanwhile, Taxotere patients continue to deal with the frustration, disappointment and emotional turmoil that are the result of what has been for some, permanent Docetaxel hair loss.Read [ Taxotere Docetaxel Side Effects Not Limited to Permanent Hair Loss ]
January 6, 2017. By Heidi Turner.
New Orleans, LA: It's only been three months since the Judicial Panel on Multidistrict Litigation (JPML) consolidated the federal Taxotere lawsuits, but in that time the number of Taxotere claims added to the multidistrict litigation (MDL) has increased dramatically, a sign that women are unhappy about allegedly being put at an increased risk of side effects. Sanofi SA faces allegations it failed to adequately warn women that the hair loss they experienced as a result of the cancer treatment drug could be permanent.Read [ Number of Consolidated Taxotere Lawsuits Jumps ]
December 22, 2016. By Gordon Gibb.
Washington, DC: The close of another year affords an opportunity to look back and review the various events that characterized the legal implications of Taxotere hair loss over the past year.Read [ Taxotere Hair Loss: a Look Back at 2016 ]